BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30824777)

  • 1. Early hospital readmissions after ABO- or HLA- incompatible living donor kidney transplantation.
    Lee J; Kim DG; Kim BS; Kim MS; Il Kim S; Kim YS; Huh KH
    Sci Rep; 2019 Mar; 9(1):3246. PubMed ID: 30824777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations.
    Ko Y; Kim JY; Kim SH; Kim DH; Lim SJ; Shin S; Kim YH; Jung JH; Park SK; Kwon H; Han DJ
    Ann Transplant; 2020 Oct; 25():e927420. PubMed ID: 33020465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excellent outcome after desensitization in high immunologic risk kidney transplantation.
    Lim JH; Cho JH; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Yoo ES; Won DI; Kim CD
    PLoS One; 2019; 14(9):e0222537. PubMed ID: 31550258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: a nationwide cohort study.
    Ko EJ; Yu JH; Yang CW; Chung BH;
    Transpl Int; 2017 Dec; 30(12):1215-1225. PubMed ID: 28493630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants.
    Pandey P; Setya D; Sinha VK; Devra AK; Bhatt AP; Pande A; Kumar P; Singh MK; Ranjan S
    J Clin Apher; 2021 Jun; 36(3):299-312. PubMed ID: 33316838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful launch of an ABO-incompatible kidney transplantation program to overcome the shortage of compatible living donors: experience at a single center
.
    Song SH; Lee J; Kim BS; Kim S; Lee JG; Jeong HJ; Kim YS; Kim MS; Kim HO; Kim SI; Huh KH
    Clin Nephrol; 2017 Sep; 88(9):117-123. PubMed ID: 28679466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
    Hamano I; Hatakeyama S; Fujita T; Murakami R; Hamaya T; Togashi K; Suzuki Y; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Narumi S; Tomita H; Ohyama C
    Transplant Proc; 2020; 52(6):1700-1704. PubMed ID: 32448659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in outcomes after antibody-mediated rejection between abo-incompatible and positive cross-match transplantations.
    Couzi L; Manook M; Perera R; Shaw O; Ahmed Z; Kessaris N; Dorling A; Mamode N
    Transpl Int; 2015 Oct; 28(10):1205-15. PubMed ID: 26095452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of desensitization therapy in kidney transplantation.
    Kim YC; Yu MY; Lee JP; Lee H; Min SI; Ha J; Kim YS
    Clin Exp Nephrol; 2018 Feb; 22(1):179-187. PubMed ID: 28634772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study.
    Lonze BE; Bae S; Kraus ES; Holechek MJ; King KE; Alachkar N; Naqvi FF; Dagher NN; Sharif A; Desai NM; Segev DL; Montgomery RA
    Transpl Int; 2017 Sep; 30(9):874-883. PubMed ID: 28403566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ABO incompatible kidney transplantation on living donor transplantation.
    Yu JH; Chung BH; Yang CW;
    PLoS One; 2017; 12(3):e0173878. PubMed ID: 28323892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report.
    Langhorst C; Ganner A; Schneider J; Prager EP; Walz G; Pisarski P; Jänigen B; Zschiedrich S
    Transplant Proc; 2021 Apr; 53(3):848-855. PubMed ID: 33041078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequelae of early hospital readmission after kidney transplantation.
    McAdams-Demarco MA; Grams ME; King E; Desai NM; Segev DL
    Am J Transplant; 2014 Feb; 14(2):397-403. PubMed ID: 24447652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of isoagglutinin titre with the current desensitization protocol in ABO-incompatible kidney transplantation.
    Baek CH; Kim H; Yang WS; Han DJ; Park SK
    Nephrology (Carlton); 2019 Jun; 24(6):654-660. PubMed ID: 29877001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation.
    Lee J; Lee JG; Kim S; Song SH; Kim BS; Kim HO; Kim MS; Kim SI; Kim YS; Huh KH
    Nephrol Dial Transplant; 2016 Jun; 31(6):1013-21. PubMed ID: 27190360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.
    Kauke T; Klimaschewski S; Schoenermarck U; Fischereder M; Dick A; Guba M; Stangl M; Werner J; Meiser B; Habicht A
    PLoS One; 2016; 11(1):e0146075. PubMed ID: 26730981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Outcomes of ABO-Incompatible Living Donor Kidney Transplantation: A Comparative Analysis.
    Shin E; Kwon SW; Yang WS; Baeck C; Yu H; Cho H; Park SK
    Transplant Proc; 2015; 47(6):1720-6. PubMed ID: 26293040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Transplantation in ABO- and HLA-Incompatible Living Kidney Transplant Patients: A Report on 12 Cases.
    Rostaing L; Karam B; Congy-Jolivet N; Hage V; Sallusto F; Esposito L; Doumerc N; Debiol B; Guilbeau-Frugier C; Game X; Allal A; Kamar N
    Ther Apher Dial; 2016 Oct; 20(5):507-516. PubMed ID: 27073167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Patterns Discriminate Accommodation and Subclinical Antibody-mediated Rejection in Kidney Transplantation.
    Hruba P; Krejcik Z; Stranecky V; Maluskova J; Slatinska J; Gueler F; Gwinner W; Bräsen JH; Wohlfahrtova M; Parikova A; Osickova K; Fronek J; Seda O; Prefertusova L; Honsova E; Viklicky O
    Transplantation; 2019 May; 103(5):909-917. PubMed ID: 30801516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.